Evidence map›Paper›PMID 38790314›Full record

ReviewBioengineering (Basel, Switzerland)2024

Wound Modulations in Glaucoma Surgery: A Systematic Review.

Bhoomi Dave, Monica Patel, Sruthi Suresh, Mahija Ginjupalli, Arvind Surya, Mohannad Albdour, Karanjit S Kooner

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Fibrous ingrowth: an overlooked cause of Ahmed Glaucoma Valve failure.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Meeting Challenges in the Diagnosis and Treatment of Glaucoma.Bioengineering (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bhoomi DaveDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Monica PatelDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Sruthi SureshDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Mahija GinjupalliDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Arvind SuryaDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0009-0005-5668-9112
Mohannad AlbdourDepartment of Ophthalmology, King Hussein Medical Center Royal Medical Services, Amman 11180, Jordan.
Karanjit S KoonerDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-2797-1750

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive fibrosis and resultant poor control of intraocular pressure (IOP) reduce the efficacy of glaucoma surgeries. Historically, corticosteroids and anti-fibrotic agents, such as mitomycin C (MMC) and 5-fluorouracil (5-FU), have been used to mitigate post-surgical fibrosis, but these have unpredictable outcomes. Therefore, there is a need to develop novel treatments which provide increased effectiveness and specificity. This review aims to provide insight into the pathophysiology behind wound healing in glaucoma surgery, as well as the current and promising future wound healing agents that are less toxic and may provide better IOP control.

Indexed as

antifibrotic agentsanti-LOXL2 monoclonal Abanti-vascular endothelial growth factorscytokine inhibitorsglaucoma surgerygrowth factor inhibitorsintegrin inhibitorswound healing

Identifiers

PMID38790314
PMCPMC11117829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.